After a stellar 2024 for recovering small to mid caps sector, our experts scour the sector for more overlooked nuggets.

There are no dead-certs in small-cap investing, but here are some plays that just might rise and shine in 2025.

Investors should ask questions about custodial-based share arrangements by which they do not have legal ownership ...

ASX rallies on commodity boost with BrainChip and DroneShield leading the charge, but 2025 volatility looms with key risks on ...

With two juniors entering trading halts, more gold M&A could be coming in 2024. With prices near record highs, 2025 looks ...

AI is beginning to influence yet more aspects of regular life, changing how Aussies with the right tech see the Boxing Day ...

The owner of a fluorspar deposit in northern WA says Japan's Sumitomo could take a 22.5% stake in a $60m JV to develop the ...

ASX rallies on commodity boost as Brainchip and Droneshield soar, while Aussies may have splashed $1.3B on Boxing Day sales.

It’s been a rocky December for investors but these stock-tipping experts still see opportunities and growth in the market.

Cancer survival has dramatically increased, but chemotherapy can lead to lasting organ damage Race plans to launch a cardioprotective study of a repurposed cancer drug, bisantrene Following an ...

Resources managed to steal the show, with two stocks gaining +190%. The winner was Sun Silver (ASX:SS1) with a 212% gain on its listing price of $0.20, even hitting highs of $1.12 in October. It’s ...